Last CNY19.04 CNY
Change Today +0.02 / 0.11%
Volume 2.1M
002412 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 11:30 PM 09/23/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for hunan hansen pharmaceutica-a (002412)

Year over year, Hunan Hansen Pharmaceutical Co., Ltd. has been able to grow revenues from CNY489.3M CNY to CNY584.7M CNY. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 56.67% to 51.73%. This was a driver that led to a bottom line growth from CNY81.5M CNY to CNY110.8M CNY.
View Income Statement In U.S. Dollar
Currency in
Millions of Chinese Renminbi (Yuan)s
As of:Dec 31
2010
Restated
CNY
Dec 31
2011
Restated
CNY
Dec 31
2012
Restated
CNY
Dec 31
2013
CNY
4 Year
Trend
Revenues343.4400.7489.3584.7
Other Revenues0.00.10.20.3
TOTAL REVENUES343.4400.8489.5584.9
Cost of Goods Sold81.696.9124.7154.9
GROSS PROFIT261.8303.9364.8430.0
Selling General & Admin Expenses, Total196.9241.6277.3302.4
Other Operating Expenses6.87.89.910.8
OTHER OPERATING EXPENSES, TOTAL203.7249.4287.2313.2
OPERATING INCOME58.054.477.6116.8
Interest Expense-1.3-2.8-0.6-0.3
Interest and Investment Income10.317.217.012.8
NET INTEREST EXPENSE9.014.416.512.4
Other Non-Operating Income (Expenses)-0.2-0.2-0.1-0.1
EBT, EXCLUDING UNUSUAL ITEMS66.868.693.9129.1
Gain (Loss) on Sale of Assets-0.10.0-0.1-0.1
Other Unusual Items, Total6.31.02.52.0
Other Unusual Items6.31.02.52.0
EBT, INCLUDING UNUSUAL ITEMS73.169.596.3130.9
Income Tax Expense11.110.714.819.8
Minority Interest in Earnings-------0.3
Earnings from Continuing Operations62.058.881.5111.1
NET INCOME62.058.881.5110.8
NET INCOME TO COMMON INCLUDING EXTRA ITEMS62.058.881.5110.8
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS62.058.881.5110.8
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002412:CH CNY19.04 CNY +0.02

002412 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002412.
View Industry Companies
 

Industry Analysis

002412

Industry Average

Valuation 002412 Industry Range
Price/Earnings 48.1x
Price/Sales 9.0x
Price/Book 5.4x
Price/Cash Flow 48.1x
TEV/Sales 8.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HUNAN HANSEN PHARMACEUTICA-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.